InnovAge Holding Corp
NASDAQ:INNV
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
P/FCFE
Price to Free Cash Flow to Equity (P/FCFE) ratio compares a company`s market value to the free cash flow available to its shareholders. It`s similar to the P/OCF ratio but more precise, since it accounts for capital expenditures deducted from operating cash flow.
Price to Free Cash Flow to Equity (P/FCFE) ratio compares a company`s market value to the free cash flow available to its shareholders. It`s similar to the P/OCF ratio but more precise, since it accounts for capital expenditures deducted from operating cash flow.
Valuation Scenarios
If P/FCFE returns to its Industry Average (21.8), the stock would be worth $6.22 (25% downside from current price).
| Scenario | P/FCFE Value | Implied Price | Upside/Downside |
|---|---|---|---|
| Current Multiple | 29.2 | $8.32 |
0%
|
| Industry Average | 21.8 | $6.22 |
-25%
|
| Country Average | 21.9 | $6.23 |
-25%
|
Forward P/FCFE
Today’s price vs future free cash flow to equity
Peer Comparison
| Market Cap | P/FCFE | P/E | ||||
|---|---|---|---|---|---|---|
| US |
|
InnovAge Holding Corp
NASDAQ:INNV
|
1.1B USD | 29.2 | 174.4 | |
| US |
|
CVS Health Corp
NYSE:CVS
|
104.3B USD | 12.3 | 59 | |
| US |
C
|
Cigna Group
XMUN:CGN
|
72.9B EUR | 12.6 | 14.1 | |
| US |
|
Cigna Corp
NYSE:CI
|
74.5B USD | 0 | 12.5 | |
| DE |
|
Fresenius SE & Co KGaA
XETRA:FRE
|
23.2B EUR | -25.1 | 18.4 | |
| DE |
|
Fresenius Medical Care AG
XMUN:FME
|
22.4B EUR | 13.9 | 22.8 | |
| US |
|
Quest Diagnostics Inc
NYSE:DGX
|
21.4B USD | 23.7 | 21 | |
| US |
|
Laboratory Corporation of America Holdings
NYSE:LH
|
21B USD | 627.8 | 24 | |
| DE |
F
|
Fresenius Medical Care AG & Co KGaA
XETRA:FME
|
10.8B EUR | 6.7 | 11 | |
| US |
|
Guardant Health Inc
NASDAQ:GH
|
11.4B USD | 69.1 | -27.5 | |
| US |
|
DaVita Inc
NYSE:DVA
|
10.4B USD | 6 | 13.9 |
Market Distribution
| Min | 0 |
| 30th Percentile | 13.1 |
| Median | 21.9 |
| 70th Percentile | 36.5 |
| Max | 3 188 432.5 |
Other Multiples
InnovAge Holding Corp
Glance View
InnovAge Holding Corp. engages in the provision of a healthcare delivery platform. The company is headquartered in Denver, Colorado and currently employs 1,800 full-time employees. The company went IPO on 2021-03-04. The firm delivers its patient-centered care through the InnovAge Platform. InnovAge Platform is focused on frail, dual-eligible seniors, and it serve participants primarily through Program of All-inclusive Care for the Elderly (PACE). InnovAge Platform provides complete, coordinated healthcare to enable its frail, nursing home-eligible seniors to live independently in their homes and communities. The InnovAge Platform consists of Interdisciplinary Care Teams and community-based care delivery model. The firm's subsidiaries include TCO Intermediate Holdings, Inc., Total Community Options, Inc., InnovAge Investment Holdings, LLC, TCO Eastern Holdings, LLC, InnovAge Pennsylvania LIFE, LLC, InnovAge Virginia PACE Roanoke Valley, LLC, InnovAge Virginia PACE II, LLC, InnovAge Virginia PACE Charlottesville, LLC, Total Longterm Care Solutions, LLC, Total Longterm Care, Inc. and InnovAge Greater Colorado PACE-Loveland, LLC.
